Zeo ScientifiX, Inc. 8-K

What Happened Zeo ScientifiX, Inc. (ZEOX) filed a Form 8-K reporting that on January 14, 2026 the company awarded 175,000 restricted shares of common stock to each of Ian Bothwell (Chief Executive Officer and Chief Financial Officer, and director) and Dr. George Shapiro (Chief Medical Officer and director). The awards were made under the company’s 2021 Incentive Stock Plan.

Key Details

• Grants: 175,000 restricted shares awarded to each of Ian Bothwell and Dr. George Shapiro.
• Grant date: January 14, 2026.
• Vesting schedule: 50% vests on the 8-month anniversary of the award date; the remaining 50% vests on the one-year anniversary.
• Recipients’ roles: Ian Bothwell serves as CEO and CFO and is a board member; Dr. George Shapiro is Chief Medical Officer and a board member.

Why It Matters Stock awards are a non-cash form of executive compensation that align executives’ interests with shareholders and provide retention incentives through the vesting schedule. When the restricted shares vest and are issued, they will increase the company’s outstanding share count (dilution), which investors should consider alongside other compensation and capital structure factors. The filing is a standard disclosure under Item 5.02 of Form 8-K.